It looks ominous and typical of a the final spike after a quick run up before a pull back. Particularily given the price run from 1.01 to 2.23 has almost repeated from 1.64 to 2.82 and the RSI is overbought on the daily and weekly.
That said, there are a couple of considerations:
- Landscape is different given the pending multiple annoucements in reasonably quick succession.
- Weekly currently above the 2007 and 2018 tops at 2.47 and Mar 2016 close at 2.67. Lets see what it looks like in a few days.
- RSI on the monthly long term is not overbought.
- Volume is increasing with the upswing.
- It broke out of a long downward trend after building support off the double/triple bottoms between 2016-19. Great base.
- Those bottoms maintain the major bottom trend line from 2005 and 2008.
Despite this stock being highly volatile historically, the above coupled with the potential significant upside vs downside make this a hold for the long term.
- Forums
- ASX - By Stock
- MSB
- The MSB pattern
MSB
mesoblast limited
Add to My Watchlist
0.93%
!
$1.63

The MSB pattern, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.63 |
Change
0.015(0.93%) |
Mkt cap ! $2.082B |
Open | High | Low | Value | Volume |
$1.63 | $1.67 | $1.61 | $6.975M | 4.265M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 707 | $1.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.64 | 7320 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 11200 | 1.625 |
11 | 72699 | 1.620 |
1 | 30000 | 1.615 |
7 | 58298 | 1.610 |
3 | 96589 | 1.605 |
Price($) | Vol. | No. |
---|---|---|
1.635 | 7000 | 1 |
1.640 | 17668 | 3 |
1.645 | 7000 | 1 |
1.650 | 37309 | 4 |
1.655 | 40000 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online